AU2003202486A1 - Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure - Google Patents
Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failureInfo
- Publication number
- AU2003202486A1 AU2003202486A1 AU2003202486A AU2003202486A AU2003202486A1 AU 2003202486 A1 AU2003202486 A1 AU 2003202486A1 AU 2003202486 A AU2003202486 A AU 2003202486A AU 2003202486 A AU2003202486 A AU 2003202486A AU 2003202486 A1 AU2003202486 A1 AU 2003202486A1
- Authority
- AU
- Australia
- Prior art keywords
- antagonist
- angiotensin
- epoxy
- treatment
- heart failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010007559 Cardiac failure congestive Diseases 0.000 title 1
- 239000002170 aldosterone antagonist Substances 0.000 title 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 201000006233 congestive heart failure Diseases 0.000 title 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003202486A AU2003202486B2 (en) | 1995-06-07 | 2003-03-26 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/486456 | 1995-06-07 | ||
AU53494/00A AU5349400A (en) | 1995-06-07 | 2000-08-18 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
AU2003202486A AU2003202486B2 (en) | 1995-06-07 | 2003-03-26 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53494/00A Division AU5349400A (en) | 1995-06-07 | 2000-08-18 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003202486A1 true AU2003202486A1 (en) | 2003-06-12 |
AU2003202486B2 AU2003202486B2 (en) | 2005-06-16 |
Family
ID=3739501
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53494/00A Abandoned AU5349400A (en) | 1995-06-07 | 2000-08-18 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
AU2003202486A Ceased AU2003202486B2 (en) | 1995-06-07 | 2003-03-26 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53494/00A Abandoned AU5349400A (en) | 1995-06-07 | 2000-08-18 | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure |
Country Status (1)
Country | Link |
---|---|
AU (2) | AU5349400A (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0400835A1 (en) * | 1989-05-15 | 1990-12-05 | Merck & Co. Inc. | Substituted benzimidazoles as angiotensin II antagonists |
US5529992A (en) * | 1992-04-21 | 1996-06-25 | Curators Of The University Of Missouri | Method for inhibiting myocardial fibrosis by administering an aldosterone antagonist which suppresses aldoster one receptors |
-
2000
- 2000-08-18 AU AU53494/00A patent/AU5349400A/en not_active Abandoned
-
2003
- 2003-03-26 AU AU2003202486A patent/AU2003202486B2/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6157796A (en) | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for treatment of congestive heart failure | |
AU4411297A (en) | Combination therapy for treatment of psychoses | |
AU5397996A (en) | Iontophoretic transdermal system for the administration of at least two substances | |
AU9035898A (en) | Electrosurgical systems and methods for the removal of pacemaker leads | |
AU4378196A (en) | Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides | |
AU6199996A (en) | Multiple therapy cardiac assist device having battery voltage safety monitor | |
AU3891299A (en) | Combination therapy for treatment of depression | |
AU4339896A (en) | Treatment of hypertension and congestive heart failure | |
AU8534291A (en) | Renal-selective angiotensin ii antagonists for treatment of hypertension | |
AU2939897A (en) | Administration of histamine for therapeutic purposes | |
AU1556497A (en) | Agents for the treatment and prevention of aids | |
AU7297998A (en) | Bariatric treatment system and relating methods | |
EP1382351B8 (en) | Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease | |
AU4163793A (en) | Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease | |
AU3062597A (en) | Defibrillator electrode circuitry | |
AU7105498A (en) | Combination therapy for the prevention and treatment of osteoporosis | |
AU6821196A (en) | Transdermal administration of vorozole | |
AU4585993A (en) | Use of angiotensin ii antagonists for the treatment of hyperlipidaeme | |
AU2003202486A1 (en) | Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapy for the treatment of congestive heart failure | |
AU2913397A (en) | Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body | |
HUP0100365A3 (en) | Combination therapy for the treatment of aids | |
AU1940800A (en) | Combination therapy for the treatment of sepsis | |
AU2003204258A1 (en) | Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure | |
AU3793597A (en) | Biphasic defibrillation circuitry | |
AU5697996A (en) | Peptidyl compounds and their therapeutic use |